No Data
No Data
Pacific Biosciences of California Selected by Davos Alzheimer's Collaborative as Technology Partner
Express News | Davos Alzheimer’s Collaborative Selects Pacbio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa
Bernstein Keeps Their Buy Rating on Pacific Biosciences (PACB)
Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2
Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk
Positive Week for Pacific Biosciences of California, Inc. (NASDAQ:PACB) Institutional Investors Who Lost 57% Over the Past Year